Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Other financing activities (2016 - 2025)

Bio Key International's Other financing activities history spans 12 years, with the latest figure at $248783.0 for Q1 2025.

  • For Q1 2025, Other financing activities rose 1746.94% year-over-year to $248783.0; the TTM value through Sep 2025 reached $273271.0, down 60.04%, while the annual FY2024 figure was $172350.0, 69.3% down from the prior year.
  • Other financing activities for Q1 2025 was $248783.0 at Bio Key International, up from $24488.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $535933.0 in Q4 2023 and bottomed at -$5228.0 in Q4 2021.
  • The 5-year median for Other financing activities is $24961.0 (2023), against an average of $113764.0.
  • The largest annual shift saw Other financing activities plummeted 522700.0% in 2021 before it skyrocketed 3067.48% in 2022.
  • A 5-year view of Other financing activities shows it stood at -$5228.0 in 2021, then surged by 3067.48% to $155140.0 in 2022, then soared by 245.45% to $535933.0 in 2023, then crashed by 95.43% to $24488.0 in 2024, then surged by 915.94% to $248783.0 in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Other financing activities are $248783.0 (Q1 2025), $24488.0 (Q4 2024), and $134392.0 (Q3 2024).